Example: Heart Attack

Search clinical trials for: Halobetasol

Total 24 results

NCT03212963

Terminated

Evaluation of Adrenal Suppression Potential and Pharmacokinetics of Halobetasol Lotion 0.05%

Conditions: Plaque Psoriasis
NCT03298581

Withdrawn

Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Plaque Psoriasis

Conditions: Plaque Psoriasis
NCT03245385

Terminated

Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis

Conditions: Atopic Dermatitis
NCT00865605

Completed

Pivotal Bioequivalence Study of Topically Delivered Halobetasol Propionate Ointment in Normal Skin in Healthy Adult Subjects

Conditions: Healthy
NCT00865267

Completed

The Dose-response Study of Topically Delivered Halobetasol Propionate Ointment in Normal Skin in Healthy Adult Subjects

Conditions: Healthy
NCT03992261

Completed

Adrenal Suppression and Absorption Study of Halobetasol Propionate Foam in Subjects 12-17 With Plaque Psoriasis

Conditions: Plaque Psoriasis
NCT00990561

Completed

Comparing the Efficacy of Ultravate Ointment in Combination With Lac-Hydrin Lotion in the Treatment of Psoriasis

Conditions: Stable Plaque Psoriasis
NCT00715975

Completed

Effectiveness and Safety of Topical Halobetasol Propionate in the Treatment of Patients With Psoriasis

Conditions: Psoriasis
NCT04720105

Recruiting

Combination of Halobetasol Propionate and Tazarotene Lotion (Duobrii®) for Palmoplantar Plaque Type Psoriasis

Conditions: Palmoplantar Psoriasis; Plaque Psoriasis
NCT01610596

Completed

A Study to Determine the Efficacy and Safety of Halobetasol Propionate Lotion 0.05% in Subjects With Plaque Psoriasis

Conditions: Psoriasis; Plaque Psoriasis
NCT00802958

Completed

Randomized Study to Compare the Bioavailability of Two Halobetasol Propionate 0.05% Topical Ointments

Conditions: Healthy
NCT00803166

Completed

Randomized Study to Compare the Bioavailability of Three Halobetasol Propionate 0.05% Topical Creams

Conditions: Healthy
NCT01111123

Completed

Ammonium Lactate Lotion 12% (Lac-hydrin®) and Halobetasol Propionate Ointment 0.05% (Ultravate®) in the Treatment and Maintenance of Psoriasis

Conditions: Plaque Psoriasis
NCT01166646

Completed

Blinded Study of Topical Investigational Lotion Vs. Approved Cream in Treatment of Plaque Psoriasis

Conditions: Plaque Psoriasis
NCT02785172

Completed

Safety and Efficacy of IDP-118 Lotion to Ultravate® in the Treatment of Plaque Psoriasis

Conditions: Psoriasis
NCT01404338

Completed

Assessment for Tachyphylaxis to Topical Corticosteroids in the Treatment of Psoriasis

Conditions: Psoriasis
NCT02785185

Completed

Safety and Efficacy of IDP-122 Lotion When Applied Topically to Subjects With Moderate to Severe Plaque Psoriasis

Conditions: Psoriasis
NCT04571151

Not yet recruiting

Efficacy and Safety of Sorilux in Maintenance Treatment of Moderate Type Plaque Psoriasis

Conditions: Plaque Psoriasis
NCT03058744

Completed

Topically Applied IDP-118 Lotion and HP Monad Lotion in Subjects With Moderate to Severe Plaque Psoriasis

Conditions: Psoriasis
NCT02462083

Completed

Long-Term Safety of IDP-118 Lotion in the Treatment of Plaque Psoriasis

Conditions: Plaque Psoriasis
NCT02515097

Completed

Safety and Efficacy of IDP-122 in the Treatment of Participants With Plaque Psoriasis

Conditions: Plaque Psoriasis
NCT02514577

Completed

Safety and Efficacy of IDP-122 in the Treatment of Participants With Plaque Psoriasis

Conditions: Plaque Psoriasis
NCT02045277

Completed

Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis

Conditions: Plaque Psoriasis
NCT00234728

Completed

Study of a New Dressing for Use With Topical Medications

Conditions: Psoriasis